Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Systemic lupus erythematosus | R-HSA-977105 | map05322 | procaine | 4914 | drug-path |
Melanogenesis | R-HSA-5662702 | map04916 | chlortetracycline | 65492 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | chlortetracycline | 65492 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | chlortetracycline | 65492 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | chlortetracycline | 65492 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | chlortetracycline | 65492 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | chlortetracycline | 65492 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | chlortetracycline | 65492 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | aciclovir | 135398513 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | aciclovir | 135398513 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | aciclovir | 135398513 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | aciclovir | 135398513 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | aciclovir | 135398513 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | aciclovir | 135398513 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | aciclovir | 135398513 | drug-path |
Asthma | R-HSA-444620 | map05310 | aciclovir | 135398513 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | aciclovir | 135398513 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | aciclovir | 135398513 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | aciclovir | 135398513 | drug-path |
Shigellosis | 0 | map05131 | aciclovir | 135398513 | drug-path |